SMS Pharmaceuticals Ltd.
Fundamentals
- Market cap
- ₹3,572 cr
- P/E
- 40.78×
- ROE
- 10.81%
- Debt / equity
- 0.49
- Div yield
- 0.10%
- 52-week range
- 207.70 — 447.80
The timeline — 3 notes on SMS Pharmaceuticals Ltd.
May 2026
- 22 May 26 · 15:20 IST Brief Brief · Earnings
SMS Pharmaceuticals books ₹87.61 cr annual profit
Annual results confirm steady growth with a final dividend of ₹0.40 per share.
- 22 May 26 · 15:16 IST Brief Brief · Earnings
SMS Pharmaceuticals hits ₹87.61 cr profit as FY26 growth hits target
Revenue climbed 13% to ₹886.87 cr, matching earlier guidance. The board approved a dividend of ₹0.40 per share.
- 22 May 26 · 13:57 IST Brief Brief · Earnings
SMS Pharmaceuticals grows FY26 revenue to ₹886.87 cr
The company’s annual results reflect steady growth alongside a final dividend of ₹0.40 per share.